EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:51164 - lisuride
| Formula | C20H26N4O |
| Net Charge | 0 |
| Average Mass | 338.455 |
| Monoisotopic Mass | 338.21066 |
| SMILES | [H][C@@]12Cc3cnc4cccc(c34)C1=C[C@H](NC(=O)N(CC)CC)CN2C |
| InChI | InChI=1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1 |
| InChIKey | BKRGVLQUQGGVSM-KBXCAEBGSA-N |
| Roles Classification |
|---|
| Biological Roles: | dopamine agonist A drug that binds to and activates dopamine receptors. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. |
| Applications: | antidyskinesia agent Any compound which can be used to treat or alleviate the symptoms of dyskinesia. dopamine agonist A drug that binds to and activates dopamine receptors. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. antiparkinson drug A drug used in the treatment of Parkinson's disease. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lisuride (CHEBI:51164) has parent hydride ergoline (CHEBI:38484) |
| lisuride (CHEBI:51164) has role antidyskinesia agent (CHEBI:66956) |
| lisuride (CHEBI:51164) has role antiparkinson drug (CHEBI:48407) |
| lisuride (CHEBI:51164) has role dopamine agonist (CHEBI:51065) |
| lisuride (CHEBI:51164) has role serotonergic agonist (CHEBI:35941) |
| lisuride (CHEBI:51164) is a monocarboxylic acid amide (CHEBI:29347) |
| Incoming Relation(s) |
| lisuride maleate (CHEBI:31776) has part lisuride (CHEBI:51164) |
| IUPAC Name |
|---|
| 1,1-diethyl-3-[(8α)-6-methyl-9,10-didehydroergolin-8-yl]urea |
| INNs | Source |
|---|---|
| lisurida | WHO MedNet |
| lisuride | ChemIDplus |
| lisuride | WHO MedNet |
| lisuridum | WHO MedNet |
| Synonym | Source |
|---|---|
| N'-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylurea | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Beilstein:4716660 | Beilstein |
| CAS:18016-80-3 | ChemIDplus |